top of page

Measure congestion. Across every care setting.

Heart failure, cardiology, and primary care

Congestion is measurable before it is visible.

Clinic Baseline → Home Assessments → Early Signal → Intervention

Closing the gap between detection and action.

Earlier Intervention.png

Opportunity for earlier intervention

A window exists to act sooner.

  • ~1–2 weeks pre-symptomatic

  • Enables therapy adjustment

  • Potential to reduce admissions

Why venous congestion must be monitored

Heart failure decompensation is primarily driven by rising venous congestion, not just declining cardiac output. 

In most patients, congestion develops days to weeks before clinical symptoms, creating a critical opportunity for earlier intervention

Traditional Assessment.png

Traditional assessment is delayed

Congestion is often detected too late.

  • Weight gain and edema are late signs

  • Physical exam is subjective

  • Intermittent visits miss progression

Congestion.png

Congestion precedes decompensation

Hemodynamic deterioration begins before symptoms.

  • Elevated CVP and venous volume

  • Reduced venous return

  • Early organ congestion

Clinic Assessment.png

Establish a baseline understanding of each patient’s congestion status.

  • Objective assessment vs. subjective exam

  • Identifies early hemodynamic changes

  • Supports treatment optimization at the point of care

Start detection at your clinic

Home Assessment.png

Monitor how congestion evolves between visits.

  • Detects trends and changes between appointments

  • Identifies early signs of decompensation

  • Enables proactive intervention to reduce admissions and readmissions

Extend visibility to the patient's home

Measure what drives heart failure hospitalizations

VenaSigns enables continuous, non-invasive assessment of venous congestion across all care settings—supporting earlier detection, more informed decision-making, and proactive heart failure management.

Comprehensive venous hemodynamic assessment

  • Central Venous Pressure (CVP)

  • Jugular Venous Distention (JVD)

  • Jugular Venous Oxygen Saturation (SjvO₂)

Designed for every care setting

From heart failure clinics and cardiology practices to primary care and home monitoring, VenaSigns delivers seamless visibility across the entire patient journey—enabling more proactive, connected care.

Request more information

Untitled design (16).png
bottom of page